Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lowenstein

Showing results (301-310 of 436) with videos related to

Pageof 44
Sort By:
Methods in Enzymology|March 9, 2002
High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brainP R Lowenstein, C E Thomas, P Umana, et al.
Trends in Cancer|October 11, 2024
Epigenetic reprogramming in pediatric gliomas: from molecular mechanisms to therapeutic implicationsSantiago Haase, Stephen Carney, Maria Luisa Varela, et al.
Handbook of Clinical Neurology|September 28, 2024
Cell and gene therapy in neuro-oncologyMaria Luisa Varela, Andrea Comba, Syed M Faisal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial designYohei Mineharu, Gwendalyn D King, A K M G Muhammad, et al.
Journal of Virology|May 28, 2004
Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cellsOliver Dorigo, Jose S Gil, Sean D Gallaher, et al.
Nature Medicine|November 1, 2005
Platelets mediate cytotoxic T lymphocyte-induced liver damageMatteo Iannacone, Giovanni Sitia, Masanori Isogawa, et al.
Current Gene Therapy|October 29, 2009
Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safetyMarianela Candolfi, Kurt M Kroeger, A K M G Muhammad, et al.
Neuro-Oncology Advances|July 10, 2020
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1Mahmoud S Alghamri, Rohit Thalla, Ruthvik P Avvari, et al.
Expert Opinion on Biological Therapy|December 13, 2022
Gene Therapy for High Grade Glioma: The Clinical ExperienceMaria Luisa Varela, Andrea Comba, Syed M Faisal, et al.
Histology and Histopathology|October 20, 2001
Gene therapy for Parkinson's disease: recent achievements and remaining challengesM G Castro, A David, A Hurtado-Lorenzo, et al.
Pageof 44

Showing results (301-310 of 436) with videos related to

Sort By:
Pageof 44
Methods in Enzymology|March 9, 2002
High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brainP R Lowenstein, C E Thomas, P Umana, et al.
Trends in Cancer|October 11, 2024
Epigenetic reprogramming in pediatric gliomas: from molecular mechanisms to therapeutic implicationsSantiago Haase, Stephen Carney, Maria Luisa Varela, et al.
Handbook of Clinical Neurology|September 28, 2024
Cell and gene therapy in neuro-oncologyMaria Luisa Varela, Andrea Comba, Syed M Faisal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial designYohei Mineharu, Gwendalyn D King, A K M G Muhammad, et al.
Journal of Virology|May 28, 2004
Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cellsOliver Dorigo, Jose S Gil, Sean D Gallaher, et al.
Nature Medicine|November 1, 2005
Platelets mediate cytotoxic T lymphocyte-induced liver damageMatteo Iannacone, Giovanni Sitia, Masanori Isogawa, et al.
Current Gene Therapy|October 29, 2009
Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safetyMarianela Candolfi, Kurt M Kroeger, A K M G Muhammad, et al.
Neuro-Oncology Advances|July 10, 2020
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1Mahmoud S Alghamri, Rohit Thalla, Ruthvik P Avvari, et al.
Expert Opinion on Biological Therapy|December 13, 2022
Gene Therapy for High Grade Glioma: The Clinical ExperienceMaria Luisa Varela, Andrea Comba, Syed M Faisal, et al.
Histology and Histopathology|October 20, 2001
Gene therapy for Parkinson's disease: recent achievements and remaining challengesM G Castro, A David, A Hurtado-Lorenzo, et al.
Pageof 44